Healthy men needed to test new Injection's safety
NCT ID NCT07376200
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing a single dose of an experimental injection called HEC-151 in healthy Chinese men aged 18 to 45. The main goal is to see if it is safe and how the body processes it. Participants will be closely monitored for side effects and changes in vital signs and heart activity. This study does not aim to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
No. 9, Shuangxing Avenue,
NOT_YET_RECRUITINGBishan, Chongqing Municipality, 402760, China
-
No. 9, Shuangxing Avenue,, Bishan
RECRUITINGChongqing, Bishan, 402760, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple vest make breathing easier?
- Chilly workouts may alter what you eat, small study suggests
- New Parkinson's drug MF1 enters first human safety trial
- AI-Powered training cuts hamstring injury risk in pro footballers
- Beta-Alanine boost for cyclists? new study reveals mixed results
- New Egg-Maturing technique could help women with low IVF success